Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL2484221 | 0.99 | CYP3A4 (0.60) | CYP3A4CRBNTNFRSF1APTGS2 | |
| Water SCHEMBL2908232 | 0.98 | CYP3A4 (0.59) | CYP3A4CRBNTNFRSF1A | |
| SCHEMBL2913043 | 0.91 | CYP3A4 (0.51) | CYP3A4CRBNPTGS2 | |
| SCHEMBL2915424 | 0.89 | CYP3A4 (0.49) | CYP3A4CRBNPTGS2 | |
| SCHEMBL2915016 | 0.87 | CYP3A4 (0.47) | CYP3A4CRBNPTGS2 | |
| SCHEMBL2913786 | 0.87 | CYP3A4 (0.47) | CYP3A4CRBNPTGS2 | |
| SCHEMBL3763864 | 0.87 | CYP3A4 (0.46) | CYP3A4CRBN | |
| SCHEMBL3651182 | 0.86 | CYP3A4 (0.47) | CYP3A4CRBN | |
| SCHEMBL2908263 | 0.86 | CYP3A4 (0.57) | CYP3A4CRBNTNFRSF1APTGS2 | |
| SCHEMBL2112795 | 0.84 | CYP3A4 (0.56) | CYP3A4CRBNTNFRSF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | claimed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | claimed |
| EP-2222646-A1 | URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C | Abbott Laboratories (US) | 2010-09-01 | — | — | EP | claimed |
| EP-2203430-A1 | N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS | Abbott Laboratories (US) | 2010-07-07 | — | — | EP | claimed |
| WO-2009039135-A1 | N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | claimed |
| WO-2009039127-A1 | URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | claimed |
| EP-2866807-A2 | METHODS FOR TREATING HCV | Abbvie Inc. (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-2685964-A1 | FORMULATIONS OF PHENYL URACIL COMPOUNDS | AbbVie Inc. (US) | 2014-01-22 | — | — | EP | disclosed |
| WO-2014004674-A2 | METHODS FOR TREATING HCV | ABBVIE INC. (US) | 2014-01-03 | — | — | WO | disclosed |
| WO-2013059638-A1 | COMBINATION TREATMENT (EG. WITH ABT-072 OR ABT -333) OF DAAS FOR USE IN TREATING HCV | ABBVIE INC. (US) | 2013-04-25 | — | — | WO | disclosed |
| WO-2013059630-A1 | METHODS FOR TREATING HCV COMPRISING AT LEAST TWO DIRECT ACTING ANTIVIRAL AGENT, RIBAVIRIN BUT NOT INTERFERON. | ABBVIE INC. (US) | 2013-04-25 | — | — | WO | disclosed |
| WO-2012129099-A1 | FORMULATIONS OF PHENYL URACIL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-09-27 | — | — | WO | disclosed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| EP-2203430-B1 | N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS | ABBOTT LAB (US) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
| EP-2222646-A1 | URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C | Abbott Laboratories (US) | 2010-09-01 | — | — | EP | disclosed |
| EP-2203430-A1 | N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS | Abbott Laboratories (US) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009039135-A1 | N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009039127-A1 | URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | disclosed |